ArticleEMBO molecular medicine2015

Atrial-like cardiomyocytes from human pluripotent stem cells are a robust preclinical model for assessing atrial-selective pharmacology.

Harsha D Devalla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.